Nobelpharma Co., Ltd.

  • Committed to our mission to fulfill unmet medical needs to see your smile
  • Committed to our mission to fulfill unmet medical needs to see your smile
  • Committed to our mission to fulfill unmet medical needs to see your smile

News & Press Release

  • Press Release
    Our project "Malaria Vaccine Development and Establishment of its Commercial Manufacturing" selected for the Cyclic Innovation for Clinical Empowerment (CiCLE) by the Japan Agency for Medical Research and Development (AMED) in the first recruitment
  • Press Release
  • Press Release
    At the Japan Venture Awards 2017, held by Organization for Small & Medium Enterprises and Regional Innovation, Japan on February 6, 2017, the President and CEO of Nobelpharma, Mr. Jin Shiomura, has received “the Economy, Trade and Industry Minister Prize”
  • Press Release
  • Press Release
    Marketing authorization for Foscavir®, antiviral chemothrapeutic agent, transferred to Clinigen KK
  • Press Release
    Titanium bridge (NPC-17) received orphan designation from MHLW
  • Press Release
    Received Lisence for Marketing Class 1 Medical Devices
  • Press Release
    NPC-04 (oxcarbazepine) Approved by PMDA for the Treatment of Partial Epilepsy
  • Press Release
    Nobelpharma signs license agreement with Danish Serendex Pharmaceuticals A/S for future commercialization of Molgradex®(inhaled GM-CSF therapy) for Pulmonary Alveolar Proteinosis in Japan
Page top